PMID- 16518880 OWN - NLM STAT- MEDLINE DCOM- 20060719 LR - 20061115 IS - 1099-498X (Print) IS - 1099-498X (Linking) VI - 8 IP - 6 DP - 2006 Jun TI - Photochemical treatment with endosomally localized photosensitizers enhances the number of adenoviruses in the nucleus. PG - 707-18 AB - BACKGROUND: In the present study the physical targeting technique photochemical internalization (PCI) has been used in combination with adenovirus. We have previously shown that PCI enhances transgene expression from AdhCMV-lacZ, and the aim of the present study was to further increase the understanding of photochemically mediated adenoviral transduction. METHODS: Two colorectal carcinoma cell lines, WiDr and HCT116, were pre-incubated with the photosensitizer TPPS(2a) or methylene blue derivates (MBD) followed by infection with adenovirus and light exposure. Transgene expression was measured by flow cytometry. Real-time polymerase chain reaction (PCR) and fluorescence in situ hybridization (FISH) were used to quantify the level of viral DNA in the nuclei. Real-time PCR was also used to measure the level of beta-galactosidase mRNA in samples infected with AdhCMV-lacZ. RESULTS: Exposing TPPS(2a)-treated cells to light enhanced the quantity of viral DNA in the nucleus, the mRNA level of the transgene and the transgene expression compared to non-illuminated cells. The increased transgene expression was independent of the promoter used, but dependent on the time of light exposure and the cellular localization of the photosensitizer. CONCLUSIONS: The enhanced transgene expression observed after photochemical treatment is most likely not a result of one event, but more an interplay between various mechanisms. An increased level of adenoviral DNA in the nucleus and a dependency of endosomal localization of the photosensitizer to obtain enhanced transgene expression suggested that endosomal rupture facilitated the transport of adenoviruses to the nucleus. CI - Copyright 2006 John Wiley & Sons, Ltd. FAU - Engesaeter, Birgit O AU - Engesaeter BO AD - Department of Tumor Biology, Rikshospitalet-Radiumhospitalet Health Enterprise, Montebello, N-0310 Oslo, Norway. birgite@labmed.uio.no FAU - Tveito, Siri AU - Tveito S FAU - Bonsted, Anette AU - Bonsted A FAU - Engebraaten, Olav AU - Engebraaten O FAU - Berg, Kristian AU - Berg K FAU - Maelandsmo, Gunhild M AU - Maelandsmo GM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Gene Med JT - The journal of gene medicine JID - 9815764 RN - 0 (DNA, Viral) RN - 0 (Photosensitizing Agents) RN - 0 (RNA, Messenger) RN - 0 (enhanced green fluorescent protein) RN - 147336-22-9 (Green Fluorescent Proteins) RN - EC 3.2.1.23 (beta-Galactosidase) SB - IM MH - Adenoviridae/*drug effects/genetics/*isolation & purification MH - Cell Line, Tumor MH - Cell Nucleus/*drug effects/*radiation effects/virology MH - DNA, Viral/genetics MH - Endosomes/*metabolism MH - Gene Expression/radiation effects MH - Genome, Viral/genetics MH - Green Fluorescent Proteins/genetics MH - HCT116 Cells MH - Humans MH - Photosensitizing Agents/metabolism/*pharmacology MH - RNA, Messenger/genetics/metabolism MH - Time Factors MH - Transduction, Genetic MH - Transgenes MH - Tumor Cells, Cultured MH - beta-Galactosidase/genetics EDAT- 2006/03/07 09:00 MHDA- 2006/07/20 09:00 CRDT- 2006/03/07 09:00 PHST- 2006/03/07 09:00 [pubmed] PHST- 2006/07/20 09:00 [medline] PHST- 2006/03/07 09:00 [entrez] AID - 10.1002/jgm.902 [doi] PST - ppublish SO - J Gene Med. 2006 Jun;8(6):707-18. doi: 10.1002/jgm.902.